Orchid Pharma Statistics

Total Valuation

Orchid Pharma has a market cap or net worth of INR 33.70 billion. The enterprise value is 35.03 billion.

Market Cap	33.70B
Enterprise Value	35.03B

Important Dates

The last earnings date was Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	50.72M
Shares Outstanding	n/a
Shares Change (YoY)	-0.30%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	23.63%
Float	15.30M

Valuation Ratios

The trailing PE ratio is 176.80 and the forward PE ratio is 22.90.

PE Ratio	176.80
Forward PE	22.90
PS Ratio	4.15
PB Ratio	2.65
P/TBV Ratio	2.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	183.78
EV / Sales	4.32
EV / EBITDA	78.38
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.22
Debt / EBITDA	6.52
Debt / FCF	n/a
Interest Coverage	0.50

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	0.51%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	11.02M
Profits Per Employee	258,986
Employee Count	736
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-2.33M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.17% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-46.17%
50-Day Moving Average	750.59
200-Day Moving Average	748.94
Relative Strength Index (RSI)	34.24
Average Volume (20 Days)	10,242

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orchid Pharma had revenue of INR 8.11 billion and earned 190.61 million in profits. Earnings per share was 3.77.

Revenue	8.11B
Gross Profit	2.76B
Operating Income	71.10M
Pretax Income	188.29M
Net Income	190.61M
EBITDA	428.55M
EBIT	71.10M
Earnings Per Share (EPS)	3.77

Full Income Statement

Balance Sheet

The company has 1.49 billion in cash and 2.82 billion in debt, with a net cash position of -1.33 billion.

Cash & Cash Equivalents	1.49B
Total Debt	2.82B
Net Cash	-1.33B
Net Cash Per Share	n/a
Equity (Book Value)	12.74B
Book Value Per Share	251.49
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 33.99%, with operating and profit margins of 0.88% and 2.35%.

Gross Margin	33.99%
Operating Margin	0.88%
Pretax Margin	2.32%
Profit Margin	2.35%
EBITDA Margin	5.28%
EBIT Margin	0.88%
FCF Margin	n/a

Dividends & Yields

Orchid Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.30%
Shareholder Yield	0.30%
Earnings Yield	0.57%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1